Eric Milledge, the former president of LifeScan Inc., was named chairman of the board of Switzerland-based CeQur SA.
The company, which houses its U.S. headquarters in Marlborough, Mass., is developing a subcutaneous insulin patch called the CeQur device for Type 2 diabetes.
The company is led by James Peterson, the former CEO of Braintree, Mass.-based Haemonetics Corp.